Recommended storage conditions for reconstituted BPC-157: Temperature: 2-8C (standard refrigeration) only do not freeze reconstituted BPC-157 Light: Continue to protect from direct light Sterile technique: Use a clean needle and alcohol wipe each time the vial is accessed Use within: 28 days of reconstitution (the shelf life of bacteriostatic water after opening) Why not freeze reconstituted BPC-157
Egrifta SV launched commercially in 2020 March 25, 2025 Egrifta WR (tesamorelin F8) Approval Ready-to-use formulation approved no reconstitution required, improved patient convenience Approved Indication Tesamorelin (Egrifta) is specifically FDA-approved for: Indication: Reduction of excess abdominal fat in HIV-infected patients with lipodystrophy HIV-associated lipodystrophy is a metabolic condition causing abnormal fat distribution, particularly visceral adipose tissue (VAT) accumulation around abdominal organs
This has led to interest in its possible use in treating nerve injuries
Full text: Sikora, M., Chrabszcz, M., Maciejewski, C., Zaremba, M., Wakiel, A., Olszewska, M., & Rudnicka, L
Its a multi-pronged attack on inflammation itself
Products containing 1% to 4% GHK-Cu provide effective concentrations for scar treatment based on available research
